Africa has used 60% of its Covid-19 vaccines, but don’t get too excited

Only 0,5% of the population is fully vaccinated, and the stalled J&J delivery has thrown a big spanner in the works

03 June 2021 - 20:19 By claire keeton

The delay in authorising Johnson & Johnson (J&J) vaccines for release after problems at a US company making the components could impact the whole continent and not only SA’s vaccine rollout, said Dr John Nkengasong, director of the Africa CDC, at his weekly Covid-19 update (https://africacdc.org/covid-19/) on Thursday.

“SA is not the only country affected. We are looking forward to using a lot of Johnson & Johnson vaccines. Our entire AVATT (African Vaccine Acquisition Task Team) strategy is underpinned by the need to have 270 million doses from J&J, with the option of taking up another 400 million,” he said...

This article is free to read if you register or sign in.

If you have already registered or subscribed, please sign in to continue.



Questions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.